5-fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: An eastern cooperative oncology group phase II study (E1889)

Jordan D. Berlin, Kathleen J. Propert, Donald Trump, George Wilding, Gary Hudes, John Glick, Patrick Burch, Alan Keller, Patrick Loehrer

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of '5-fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: An eastern cooperative oncology group phase II study (E1889)'. Together they form a unique fingerprint.

Medicine & Life Sciences